Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matloob Ahmad

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Pakistan Journal of Pharmaceutical Sciences|January 3, 2020
Design, synthesis, in-silico study and anticancer potential of novel n-4- piperazinyl-ciprofloxacin-aniline hybridsRabia Akhtar, Ameer Fawad Zahoor, Azhar Rasul, et al.
Frontiers in Chemistry|November 21, 2022
Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitorsNoureen Ashraf, Asnuzilawati Asari, Numan Yousaf, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Identification of Cyclic Sulfonamides with an <i>N-</i>Arylacetamide Group as α-Glucosidase and α-Amylase Inhibitors: Biological Evaluation and Molecular ModelingFurqan Ahmad Saddique, Matloob Ahmad, Usman Ali Ashfaq, et al.
Chemical & Pharmaceutical Bulletin|March 2, 2010
Antimicrobial and antileishmanial studies of novel (2E)-3-(2-chloro-6-methyl/methoxyquinolin-3-yl)-1-(aryl)prop-2-en-1-onesSyed Umar Farooq Rizvi, Hamid Latif Siddiqui, Masood Parvez, et al.
Archives of Pharmacal Research|July 10, 2013
Synthesis and anti-HIV-1 screening of novel N'-(1-(aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(1H)-yl)acetohydrazidesSana Aslam, Matloob Ahmad, Muhammad Zia-Ur-Rehman, et al.
Drug Design, Development and Therapy|May 13, 2024
A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic CompoundsMuhammad Shahid Nazir, Matloob Ahmad, Sana Aslam, et al.
Plos One|February 3, 2021
Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approachUsman Ali Ashfaq, Saman Saleem, Muhammad Shareef Masoud, et al.
BMC Chemistry|August 7, 2019
Evaluation of structurally different benzimidazoles as priming agents, plant defence activators and growth enhancers in wheatArruje Hameed, Amjad Hameed, Tahir Farooq, et al.
Toxicology and Applied Pharmacology|September 8, 2023
Pharmacological and toxicological evaluation of methyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxoide against haloperidol induced Parkinson like symptoms in animal model: In-vitro and in-vivo studiesLiaqat Hussain, Ina Masood, Matloob Ahmad, et al.
Bioorganic Chemistry|July 12, 2018
Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivativesShakeel Ahmad, Sumera Zaib, Saquib Jalil, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Pakistan Journal of Pharmaceutical Sciences|January 3, 2020
Design, synthesis, in-silico study and anticancer potential of novel n-4- piperazinyl-ciprofloxacin-aniline hybridsRabia Akhtar, Ameer Fawad Zahoor, Azhar Rasul, et al.
Frontiers in Chemistry|November 21, 2022
Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitorsNoureen Ashraf, Asnuzilawati Asari, Numan Yousaf, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Identification of Cyclic Sulfonamides with an <i>N-</i>Arylacetamide Group as α-Glucosidase and α-Amylase Inhibitors: Biological Evaluation and Molecular ModelingFurqan Ahmad Saddique, Matloob Ahmad, Usman Ali Ashfaq, et al.
Chemical & Pharmaceutical Bulletin|March 2, 2010
Antimicrobial and antileishmanial studies of novel (2E)-3-(2-chloro-6-methyl/methoxyquinolin-3-yl)-1-(aryl)prop-2-en-1-onesSyed Umar Farooq Rizvi, Hamid Latif Siddiqui, Masood Parvez, et al.
Archives of Pharmacal Research|July 10, 2013
Synthesis and anti-HIV-1 screening of novel N'-(1-(aryl)ethylidene)-2-(5,5-dioxido-3-phenylbenzo[e]pyrazolo[4,3-c][1,2]thiazin-4(1H)-yl)acetohydrazidesSana Aslam, Matloob Ahmad, Muhammad Zia-Ur-Rehman, et al.
Drug Design, Development and Therapy|May 13, 2024
A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic CompoundsMuhammad Shahid Nazir, Matloob Ahmad, Sana Aslam, et al.
Plos One|February 3, 2021
Rational design of multi epitope-based subunit vaccine by exploring MERS-COV proteome: Reverse vaccinology and molecular docking approachUsman Ali Ashfaq, Saman Saleem, Muhammad Shareef Masoud, et al.
BMC Chemistry|August 7, 2019
Evaluation of structurally different benzimidazoles as priming agents, plant defence activators and growth enhancers in wheatArruje Hameed, Amjad Hameed, Tahir Farooq, et al.
Toxicology and Applied Pharmacology|September 8, 2023
Pharmacological and toxicological evaluation of methyl 4-hydroxy-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxoide against haloperidol induced Parkinson like symptoms in animal model: In-vitro and in-vivo studiesLiaqat Hussain, Ina Masood, Matloob Ahmad, et al.
Bioorganic Chemistry|July 12, 2018
Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2,1-benzothiazine-2,2-dioxide derivativesShakeel Ahmad, Sumera Zaib, Saquib Jalil, et al.
Pageof 10